Treprostinil is a synthetic analogue of prostacyclin (PGI2) that causes direct vasodilation of pulmonary and systemic arterial vascular beds and inhibits platelet aggregation. It is used in the treatment of pulmonary arterial hypertension to improve exercise capacity and reduce symptoms of the disease.
Treprostinil is a synthetic analogue of prostacyclin (PGI2) that causes direct vasodilation of pulmonary and systemic arterial vascular beds and inhibits platelet aggregation. It is used in the treatment of pulmonary arterial hypertension to improve exercise capacity and reduce symptoms of the disease.
| Parameter | Specification |
|---|---|
| Chemical Name | Treprostinil |
| CAS Number | 81846-19-7 |
| Molecular Formula | C₂₃H₃₄O₅ |
| Molecular Weight | 390.51 g/mol |
| Purity | ≥ 99.0% |
| Appearance | White to off-white crystalline solid |
| Solubility | Slightly soluble in water; soluble in alcohol |
| Grade | Pharmaceutical Grade |
| Storage | Store below 30°C, protect from light and moisture |
| Batch Size | 10 grams to 250 kg lots |
| Available Documentation | CoA, CoO, DMF, MSDS |
Patent Notice: Products under patents are offered subject to the patent laws of the importing countries. The buyer is solely responsible for compliance with patent rights in any specific country.